Table 1

Oligonucleotides used throughout these experiments

Oligo no.

sequence

#139

5'-CCCAAGCTTTCTAGACTCGAGCTACAAAATCCTTTC

#377

5'-CTGAAGCGCGCACGGCAAGAGGCGAGGGGAGGCGACTG

#480

5'-GCGCGCTTCAGCAAGC

#481

5'-GCGCGCACGGCAAGA

#559

5'-CTTTACGATGCCATTGGGA

#626

5'-TGTCTTAAGTATAGTGAATCGCGTTCGCCAAGGATACTCACCA

#628

5'-CCCCTCGGGATTGGGAGGTGGGTTTGGAAGCTTAGTGGTGAGTATCC

#796

5'-TGAGGTTACCGTTCTTTCTATT

#797

5'-GATCCCGGGATCCTCGGGATTGGGAGGTGGGTCTGAAAAGAAAGAGGAGAATAACCTTGACGAACACGGTTAGCAATAGAAAGAAC

#798

5'-TGAACTAGTAGGTTTAAGAATAGTTTTTGCTGTTCTTTCTATT

#800

5'-TGAGGTTACCGTACTTTCTATAGTGAAT

#918

5'-GCTATGTCGACAAGGAGCTGCAGATCGATGAATTCGATACTTACCAGTCGCCTCCCCTC

#931

5'-GCTATGTCGACACCCAATTCTGAAACGATAATGGTGAATATCCCTGCCTAACTCTATTCACTATA

#932

5'-ATCCTGCAGAATAGTTTTTGCTGTACTTTCTATAGTGA

#936

5'-ACTGGTTACCACATATCTATGAAACT

#939

5'-ACAGGATCCATCCCCGGGCTGAAATGGATAAACA

#940

5'-ACTGGTTACCTGTACCAATTGCTATT

#941

5'-ACAGGATCCATCCCCGGGCTAAGGCTTTTGTCAT

#942

5'-ACTGGTTACCAAAAAGTGTTGCTTTC

#943

5'-ACAGGATCCATCCCCGGGCTGCCATAGGAGATGC

#945

5'-ACAGGATCCATCCCCGGGCTGAAAAACAGTCAAA

#946

5'-ACTGGTTACCACCCTGAATTAGCAGA

#947

5'-ACAGGATCCATCCCCGGGCTGTAATAAACCCGAA

#948

5'-ACTGGTTACCTAGCAACAGACATACA

#985

5'-GATGGATCCCGGGCTCGGGATTGGGAG

#986

5'-TGAGGTTACCGTCTTAAGTATA

#1065

5'-ATCCCCGGGCTGAAACGATAATGGTGA

#1088

5'-ACAGGATCCATCCCCGGGTGCTTTGATAGAGAAG

#1089

5'-ACAGGATCCATCCCCGGGCTTTCCAGAGGAGCTT

#1091

5'-ACAGGATCCATCCCCGGGCTTGTTATGTCCTGCT

#1183

5'-CTAGAATTCAGCAACAGACATACA

#1224

5'-TCTTCCAGCCTCCCATCAGCGTTTGG

#1225

5'-CAACAGAAATCCAACCTAGAGCTGCT

#1388

5'-TGAGGTTACCAAAAAGTGTTGCTTTCATTGCCACGTTTGTTTCATGAC

#1389

5'-ATCCCCGGGCTGAAAGAGGAGAAGGCGAGGGCGTTTGTCATGAAAC

#1481

5'-ATCCCCGGGCTGAAAGAGGAGAAGGCTAGGGCTTTTGTCATGAAAC

#1482

5'-TGAGGTTACCAAAAAGTGTGGCGTCCGTTGCCACGTTTGTTTCATGAC

#1483

5'-ATCCCCGGGCTGCCATAGGAGATGCCGAAGGCGTTTGTCATGAAAC

#1484

5'-ATCCCCGGGCTGCCATAGGAGATGCCGAAGGCGTTTGTTAGTAAAC

#1486

5'-ATCCCCGGGCTGAAATAGGAGATGCCTAAGGCTTTTGTCATGAAAC

#1492

5'-ACAGGATCCATCCCCGGGAGGGCTCTAGTCTAGG

#1542

5'-CACCTTCTTCTTCTATTCCTT

#1544

5'-CTTGAAAGCGAAAGTAAAGC

#1586

5'-TGAGGTTACCAAAAAGTGTGGCGTCCGTTGCCACGTTTGTTTACTAAC

#1587

5'-ATCCCCGGGCTGAAAGAGGAGAAGGCGAGGGCGTTTGTTAGTAAAC

#1590

5'-ATCCCCGGGCTGAAAGAGGAGAAGGCGAGGGCGTTTGTCATGAAAC

#1591

5'-TGAGGTTACCAAAAAGTGTTGCTTTCATTGCCACGTTTGTTTCATGAC

#1592

5'-ATCCCCGGGCTGAAATAGGAGATGCCGAAGGCGTTTGTTAGTAAAC

#1913

5'-TACTGCAGTACTTTTATGTCACTATTATCTTGTATTACTACTGCCCCTTCACCTTTCCAGAGGAGCTTTGCTG

#1913a

5'-CTACTGCAGTACTTTTATGTCACTATTATCTTGTATTACTACTGCCCCTTCACCTTTCCAGAGGAGCTTTGCTGGTCGATAGCAAACTGGATCTCTG

#1913b

5'-CTACTGCAGTACTTTTATGTCACTATTATCTTGTATTACTACTGCCCCTTCACGATAGCAGAGGAGCTTTGCTG

#2183

5'-GGTCAGGGTCTACTTGTGTGC

#2335

5'-GGGTCTCTCTGGTTAGACCAG

Kammler et al. Retrovirology 2006 3:89   doi:10.1186/1742-4690-3-89